Dr. Fournier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd Ne
Atlanta, GA 30322Phone+1 404-778-3444Fax+1 404-778-3495- Is this information wrong?
Education & Training
- Tufts Medical CenterResidency, Neurology, 2008 - 2011
- St Elizabeth's Medical CenterInternship, Internal Medicine, 2007 - 2008
- Medical College of Georgia at Augusta UniversityClass of 2007
Certifications & Licensure
- GA State Medical License 2011 - 2024
- NC State Medical License 2020 - 2022
- AL State Medical License 2020 - 2020
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, Adriano Chio, Ammar Al-Chalabi, Philip Van Damme, Chris McDermott, Jonathan Glass, James Berry, Ruben P A van Eijk, Ch...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 May 1
- The importance of understanding minimal important difference for ALSFRS-R: A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' htt...Christina N Fournier, Jonathan D Glass> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 Feb 1
- Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey.Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow, Christina Nicole Fournier> ;Journal of the Neurological Sciences. 2023 Sep 15
- Join now to see all
Journal Articles
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
- Long-Term Use of IV Edaravone Shows No Significant Slowing of ALS ProgressionJanuary 27th, 2022
- ALS: Edaravone Addition to Riluzole Does Not Change Disease ProgressionJanuary 11th, 2022
- Does Edaravone Slow ALS Progression?January 10th, 2022
Hospital Affiliations
- Atlanta Veterans Affairs Medical CenterDecatur, Georgia
- Emory University HospitalAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: